{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:59:41Z","timestamp":1757703581692},"reference-count":17,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"DOI":"10.1210\/jc.2012-1792","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:32:27Z","timestamp":1340411547000},"page":"3051-3055","source":"Crossref","is-referenced-by-count":5,"title":["Resorptive Hypercalcemia in Post-Essential Thrombocythemia Myelofibrosis: Treatment with Denosumab"],"prefix":"10.1210","volume":"97","author":[{"given":"Nadia","family":"Khoury","sequence":"first","affiliation":[{"name":"Departments of Endocrinology and Diabetes (N.K.), St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julietta","family":"Chang","sequence":"additional","affiliation":[{"name":"Medicine (J.C.), St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[{"name":"Pathology and Immunology (A.A.G.), St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Whyte","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral Diseases (M.P.W.), Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri 63110"},{"name":"Center for Metabolic Bone Disease and Molecular Research, Shriners Hospital for Children (M.P.W.), St. Louis, Missouri 63131"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113310478700_B1","first-page":"105","article-title":"Hypercalcemia and adrenal insufficiency in a patient with myelofibrosis.","volume":"63","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041113310478700_B2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer.","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113310478700_B3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline.","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113310478700_B4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.med.60.041707.160528","article-title":"Primary myelofibrosis: update on definition, pathogenesis, and treatment.","volume":"60","author":"Abdel-Wahab","year":"2009","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t2019041113310478700_B5","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/jbmr.5650061413","article-title":"Differential diagnosis of hypercalcemia.","volume":"6","author":"Lafferty","year":"1991","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113310478700_B6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14310\/horm.2002.1225","article-title":"Medical treatment of hypercalcaemia.","volume":"8","author":"Makras","year":"2009","journal-title":"Hormones (Athens)"},{"key":"key\n\t\t\t\t2019041113310478700_B7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/9780470623992.ch80","article-title":"Hematologic malignancies and bone","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"McHayley","year":"2008","edition":"7th ed"},{"key":"key\n\t\t\t\t2019041113310478700_B8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-9343(77)90843-9","article-title":"Acute myelofibrosis and malignant hypercalcemia.","volume":"62","author":"Libnoch","year":"1977","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113310478700_B9","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2010-11-315614","article-title":"How I treat myelofibrosis.","volume":"117","author":"Tefferi","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113310478700_B10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia.","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113310478700_B11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4065\/74.12.1233","article-title":"Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis.","volume":"74","author":"Kumar","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019041113310478700_B12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajh.2830390316","article-title":"Hypercalcemia in idiopathic myelofibrosis: modulation of calcium and collagen homeostasis by 1,25-dihydroxyvitamin D3.","volume":"39","author":"Voss","year":"1992","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041113310478700_B13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000208401","article-title":"Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia.","volume":"49","author":"Licht","year":"1973","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t2019041113310478700_B14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2257.1988.tb01149.x","article-title":"Hydroxyprolinuria and hypercalcaemia during immobilization in patients with idiopathic myelofibrosis.","volume":"10","author":"Baglin","year":"1988","journal-title":"Clin Lab Haematol"},{"key":"key\n\t\t\t\t2019041113310478700_B15","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","article-title":"Advances in the biology and treatment of bone disease in multiple myeloma.","volume":"17","author":"Raje","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113310478700_B16","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future.","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113310478700_B17","volume-title":"Denosumab","year":"2011"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/9\/3051\/9046629\/jcem3051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T02:49:56Z","timestamp":1561862996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/9\/3051\/2536799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-1792","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,1]]}}}